Eden Research plc (EDEN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eden Research plc (EDEN) has a cash flow conversion efficiency ratio of -0.048x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-508.02K ≈ $-61.81 USD) by net assets (GBX10.61 Million ≈ $1.29K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Eden Research plc worth for the company's overall valuation and market capitalisation.
Eden Research plc - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Eden Research plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eden Research plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eden Research plc ranked by their cash flow conversion efficiency. Explore Eden Research plc (EDEN) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ImmuPharma PLC
LSE:IMM
|
-2.979x |
|
Mineral & Financial Investments Ltd
LSE:MAFL
|
0.012x |
|
JDC Group AG
XETRA:JDC
|
0.053x |
|
TEVANO SYSTEMS HLDGS INC.
F:7RBA
|
N/A |
|
Rua Life Sciences PLC
LSE:RUA
|
0.004x |
|
Artisanal Spirits Company PLC
LSE:ART
|
-0.155x |
|
OVATION SCIENCE I
F:0VH
|
N/A |
|
Vicarious Surgical Inc.
NYSE:RBOT
|
-1.772x |
Annual Cash Flow Conversion Efficiency for Eden Research plc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Eden Research plc from 2004 to 2024. View EDEN live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX11.84 Million ≈ $1.44K |
GBX-1.01 Million ≈ $-122.71 |
-0.085x | +31.93% |
| 2023-12-31 | GBX13.55 Million ≈ $1.65K |
GBX-1.70 Million ≈ $-206.28 |
-0.125x | -96.84% |
| 2022-12-31 | GBX10.74 Million ≈ $1.31K |
GBX-683.10K ≈ $-83.11 |
-0.064x | +49.60% |
| 2021-12-31 | GBX12.83 Million ≈ $1.56K |
GBX-1.62 Million ≈ $-196.93 |
-0.126x | -85.50% |
| 2020-12-31 | GBX14.93 Million ≈ $1.82K |
GBX-1.02 Million ≈ $-123.53 |
-0.068x | +50.68% |
| 2019-12-31 | GBX7.35 Million ≈ $894.00 |
GBX-1.01 Million ≈ $-123.29 |
-0.138x | -62.68% |
| 2018-12-31 | GBX8.28 Million ≈ $1.01K |
GBX-701.68K ≈ $-85.37 |
-0.085x | -413.74% |
| 2017-12-31 | GBX8.51 Million ≈ $1.04K |
GBX230.04K ≈ $27.99 |
0.027x | +122.68% |
| 2016-12-31 | GBX6.76 Million ≈ $822.88 |
GBX-805.79K ≈ $-98.04 |
-0.119x | -573.42% |
| 2015-12-31 | GBX5.93 Million ≈ $721.13 |
GBX-104.86K ≈ $-12.76 |
-0.018x | +88.70% |
| 2014-12-31 | GBX5.94 Million ≈ $723.09 |
GBX-930.29K ≈ $-113.19 |
-0.157x | +28.64% |
| 2013-12-31 | GBX5.68 Million ≈ $691.04 |
GBX-1.25 Million ≈ $-151.60 |
-0.219x | +25.48% |
| 2012-12-31 | GBX5.51 Million ≈ $670.17 |
GBX-1.62 Million ≈ $-197.29 |
-0.294x | +39.67% |
| 2011-12-31 | GBX5.39 Million ≈ $655.32 |
GBX-2.63 Million ≈ $-319.75 |
-0.488x | +27.47% |
| 2010-12-31 | GBX2.60 Million ≈ $316.71 |
GBX-1.75 Million ≈ $-213.05 |
-0.673x | -640.58% |
| 2009-12-31 | GBX4.76 Million ≈ $578.67 |
GBX-432.00K ≈ $-52.56 |
-0.091x | +62.74% |
| 2008-12-31 | GBX5.25 Million ≈ $639.22 |
GBX-1.28 Million ≈ $-155.84 |
-0.244x | -557.04% |
| 2007-12-31 | GBX6.16 Million ≈ $749.53 |
GBX-228.59K ≈ $-27.81 |
-0.037x | +87.18% |
| 2006-12-31 | GBX4.36 Million ≈ $530.54 |
GBX-1.26 Million ≈ $-153.62 |
-0.290x | -162.68% |
| 2005-12-31 | GBX6.40 Million ≈ $778.44 |
GBX-705.24K ≈ $-85.81 |
-0.110x | -614.78% |
| 2004-12-31 | GBX8.98 Million ≈ $1.09K |
GBX-138.42K ≈ $-16.84 |
-0.015x | -- |
About Eden Research plc
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such a… Read more